Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study

Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study

In our retrospective cohort study, we aim to explore whether Azvudine modifies the risk of death in COVID-19 patients. It was conducted on the medical records of patients, consecutively admitted for COVID-19 pneumonia to two hospitals in Chongqing, China. Based on Azvudine treatment exposure, the pa...

Full description

Bibliographic Details
Main Authors:	Kaican Zong, Hui Zhou, Wen Li, E Jiang, Yi Liu, Shiying Li
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	Azvudine COVID-19 Pneumonia Mortality
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383523002575

Similar Items

Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study
by: Xiaomin Wang, et al.
Published: (2023-12-01)

Effectiveness of azvudine in reducing mortality of COVID-19 patients: a systematic review and meta-analysis
by: Yaqi Wang, et al.
Published: (2024-02-01)

Is Azvudine Comparable to Nirmatrelvir-Ritonavir in Real-World Efficacy and Safety for Hospitalized Patients with COVID-19? A Retrospective Cohort Study
by: Qinqin Zhao, et al.
Published: (2023-07-01)

Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study
by: Mei-Ping Chen, et al.
Published: (2024-02-01)

Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching
by: An-Hua Wei, et al.
Published: (2023-10-01)

Antiviral effectiveness and survival correlation of azvudine and nirmatrelvir/ritonavir in elderly severe patients with COVID-19: a retrospective real-world studyResearch in context
by: Shuxia Wang, et al.
Published: (2024-03-01)

Comparison of Azvudine and Nirmatrelvir/Ritonavir and Combined Use in Patients with COVID-19
by: Hu CY, et al.
Published: (2023-12-01)

Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19: a retrospective observational study
by: Zhiguo Zhou, et al.
Published: (2024-01-01)

Efficacy of Nirmatrelvir-Ritonavir versus Azvudine for COVID-19 Treatment in Tibet: A Retrospective Study
by: Zhao X, et al.
Published: (2023-09-01)

Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants
by: Xi Zhang, et al.
Published: (2023-05-01)

Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients
by: Peng Su, et al.
Published: (2024-01-01)

Inflammatory predictors (eosinophil, C-RP and IL-6) and effectiveness of oral Azvudine tablets treatment in COVID-19 hospitalized patients: A retrospective, self-controlled study
by: Yanli Zhao, et al.
Published: (2023-11-01)

Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing: a multicenter retrospective cohort study
by: Xiaobo Han, et al.
Published: (2024-01-01)

A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study
by: Zhigang Ren, et al.
Published: (2020-10-01)

Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with Azvudine
by: Manyun Mao, et al.
Published: (2023-10-01)

Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness: a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial
by: Xinlun Tian, et al.
Published: (2024-01-01)

Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort studyResearch in context
by: Yuming Sun, et al.
Published: (2023-05-01)

Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis
by: Zhaoyan Chen, et al.
Published: (2023-09-01)

Bacterial co-infection raises in-hospital mortality of COVID-19 patients: a retrospective study
by: Kaican Zong, et al.
Published: (2023-06-01)

Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients
by: Sávio Bastos de Souza, et al.
Published: (2023-10-01)

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials
by: Ke-Wei Zhu
Published: (2023-08-01)

Effect of Azovudine on Hepatic and Renal Function in Patients with COVID-19: a Case Series Study
by: HE Mei, LI Hui, MU Lifeng, YANG Ming
Published: (2023-07-01)

FNC: An Advanced Anticancer Therapeutic or Just an Underdog?
by: Daria Fayzullina, et al.
Published: (2022-02-01)

In-hospital mortality for aspiration pneumonia in a tertiary teaching hospital: A retrospective cohort review from 2008 to 2018
by: Dongho Shin, et al.
Published: (2023-03-01)

Serial viral load analysis by DDPCR to evaluate FNC efficacy and safety in the treatment of mild cases of COVID-19
by: Renato Martins da Silva, et al.
Published: (2023-03-01)

Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort study
by: Chan MC, et al.
Published: (2016-05-01)

Risk factors for in-hospital mortality and secondary bacterial pneumonia among hospitalized adult patients with community-acquired influenza: a large retrospective cohort study
by: Guangzhao Yi, et al.
Published: (2023-03-01)

Clinical profile analysis and nomogram for predicting in-hospital mortality among elderly severe community-acquired pneumonia patients: a retrospective cohort study
by: Chang Wei, et al.
Published: (2024-01-01)

Composite Interventions on Outcomes of Severely and Critically Ill Patients with COVID-19 in Shanghai, China
by: Jiasheng Shao, et al.
Published: (2023-07-01)

Antimicrobial resistance and risk factors for mortality of pneumonia caused by Klebsiella pneumoniae among diabetics: a retrospective study conducted in Shanghai, China
by: Liu B, et al.
Published: (2019-05-01)

The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis
by: Yue-Nan Ni, et al.
Published: (2019-03-01)

Characteristics and outcomes of patients admitted to a tertiary academic hospital in Pretoria with HIV and severe pneumonia: a retrospective cohort study
by: Veronica Ueckermann, et al.
Published: (2022-06-01)

Predictors of mortality of hospitalized COVID-19 pneumonia patients in university hospital
by: Safa M. Wafy, et al.
Published: (2024-03-01)

Analysis of mortality risk factors in children with severe adenovirus pneumonia: A single-center retrospective study
by: Xue-Hua Xu, et al.
Published: (2023-05-01)

Impact of macrolide therapy on mortality of HIV-infected patients with community-acquired pneumonia in a tertiary teaching hospital
by: Claudia Figueiredo Mello, et al.

Clinical and Microbiological Prognostic Factors of in-Hospital Mortality Caused by Hypervirulent Klebsiella pneumoniae Infections: A Retrospective Study in a Tertiary Hospital in Southwestern China
by: Tang Y, et al.
Published: (2020-10-01)

Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China
by: Xin Ding, et al.
Published: (2022-12-01)

Platelet-to-White Blood Cell Ratio as a Predictor of Mortality in Patients with Severe COVID-19 Pneumonia: A Retrospective Cohort Study
by: Thungthienthong M, et al.
Published: (2023-01-01)

Eosinopenia Predicting Long-term Mortality in Hospitalized Acute Exacerbation of COPD Patients with Community-acquired Pneumonia—A Retrospective Analysis
by: Mao Y, et al.
Published: (2021-12-01)

Predictors of Length of Stay, Rehospitalization and Mortality in Community-Acquired Pneumonia Patients: A Retrospective Cohort Study
by: Giorgia Lüthi-Corridori, et al.
Published: (2023-08-01)